GSK's Walmsley Focused On Upcoming Launches Amid 'Uncertain' Times

New CEO confirmed GSK's commitment to maintaining its three business unit structure ‒ "as long as all three businesses continue to perform competitively" ‒ as she chaired her first quarterly results presentation at the helm of the big pharma.